Avalon Pharma renews SAR 50M credit agreement with Alinma Bank

Middle East Pharmaceutical Industries Co. (Avalon Pharma) renewed its SAR 50 million credit facility agreement with Alinma Bank to support its working capital and capital expenditure.

In a statement to Tadawul, the company said the one-year facility was obtained on May 15, 2025.

The collateral provided includes a promissory note valued at SAR 55 million.

There are no related parties to the deal, the statement added.